A
Armin Ruf
Researcher at Hoffmann-La Roche
Publications - 43
Citations - 3063
Armin Ruf is an academic researcher from Hoffmann-La Roche. The author has contributed to research in topics: Allosteric regulation & Fructose 1,6-bisphosphatase. The author has an hindex of 24, co-authored 43 publications receiving 2682 citations.
Papers
More filters
Journal ArticleDOI
Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose
Claudia Ferrara,Sandra Grau,Christiane Jäger,Peter Sondermann,Peter Brünker,Inja Waldhauer,Michael Hennig,Armin Ruf,Arne C. Rufer,Martine Stihle,Pablo Umana,Jörg Benz +11 more
TL;DR: A detailed, molecular understanding of the regulatory role of Fc-oligosaccharide core fucosylation in improving ADCC is obtained and a unique mechanism by which the immune system can regulate antibody-mediated effector functions is suggested.
Journal ArticleDOI
A general protocol for the generation of Nanobodies for structural biology
Els Pardon,Toon Laeremans,Sarah Triest,Søren G. F. Rasmussen,Alexandre Wohlkonig,Armin Ruf,Serge Muyldermans,Wim G. J. Hol,Brian K. Kobilka,Jan Steyaert +9 more
TL;DR: A general protocol for the generation of Nanobodies to be used as crystallization chaperones for the structural investigation of diverse conformational states of flexible (membrane) proteins and complexes thereof.
Journal ArticleDOI
Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase
Ralf Thoma,Tanja Schulz-Gasch,Brigitte D'Arcy,Jörg Benz,Johannes Aebi,Henrietta Dehmlow,Michael Hennig,Martine Stihle,Armin Ruf +8 more
TL;DR: The target protein with an inhibitor that showed cholesterol lowering in vivo opens the way for the structure-based design of new OSC inhibitors, and the complex with the reaction product lanosterol gives a clear picture of the way in which the enzyme achieves product specificity in this highly exothermic cyclization reaction.
Journal ArticleDOI
Structural Basis of Proline-Specific Exopeptidase Activity as Observed in Human Dipeptidyl Peptidase-IV
TL;DR: Inhibition of dipeptidyl peptidase IV (DPP-IV), the main glucagon-like peptide 1 (GLP1)-degrading enzyme, has been proposed for the treatment of type II diabetes and the X-ray structure at 2.1 A resolution is determined.
Journal ArticleDOI
Structure of the Acid-sensing ion channel 1 in complex with the gating modifier Psalmotoxin 1
Roger J. P. Dawson,Jörg Benz,Peter Stohler,Tim Tetaz,Catherine Joseph,Sylwia Huber,Georg Schmid,Daniela Hügin,Pascal Pflimlin,Gerd Trube,Markus G. Rudolph,Michael Hennig,Armin Ruf +12 more
TL;DR: The results provide a general concept for gating modifier toxin binding suggesting that both surface motifs are required to modify the gating characteristics of an ion channel.